Urologix, Inc. (Nasdaq: ULGX),
the leading provider of in-office BPH therapy, today announced that it has
reached an important milestone in its licensing agreement with Medtronic for
the Prostiva RF Therapy System. In accordance with the terms of...
MINNEAPOLIS, July 18, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, announced today it has received a letter of determination from The
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.